The impairment of insulin signaling in Alzheimer's disease

被引：69

作者：

Candeias, Emanuel ^{[1
]}

Duarte, Ana I. ^{[1
]}

Carvalho, Cristina ^{[1
,2
]}

Correia, Sonia C. ^{[1
,2
]}

Cardoso, Susana ^{[1
,2
]}

Santos, Renato X. ^{[1
,2
]}

Placido, Ana I. ^{[1
]}

Perry, George ^{[4
]}

Moreira, Paula I. ^{[1
,3
]}

机构：

[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal

[2] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3004517 Coimbra, Portugal

[3] Univ Coimbra, Fac Med, Physiol Lab, P-3004517 Coimbra, Portugal

[4] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA

来源：

IUBMB LIFE | 2012年 / 64卷 / 12期

关键词：

aging; Alzheimer's disease; type; 2; diabetes; insulin signaling; THERAPEUTIC TARGET; GLUCOSE-METABOLISM; BRAIN; RESISTANCE; MITOCHONDRIA; DYSFUNCTION; DEMENTIA; RECEPTOR; PATHWAY; RISK;

D O I：

10.1002/iub.1098

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alterations of the insulin signaling cascade underlie cognitive decline and the development of several neurodegenerative diseases. In recent years, a great interest has been put in studying the interaction between diabetes and Alzheimer's disease (AD). In fact, evidence shows that both diseases present several biochemical similarities including defects in the insulin signaling pathway. Here, we give an overview of the main functions of insulin in the central nervous system. The impact of insulin signaling impairment in brain aging and AD is also discussed. Finally, we present evidence supporting the notion that insulin is a link between diabetes and AD. (C) 2012 IUBMB IUBMB Life, 64(12): 951957, 2012

引用

页码：951 / 957

页数：7

共 50 条

[1] Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease
Holscher, Christian
[J]. FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
[2] Insulin Signaling in Sporadic Alzheimer's Disease
Liao, Francesca-Fang
Xu, Huaxi
[J]. SCIENCE SIGNALING, 2009, 2 (74)
[3] The rise and fall of insulin signaling in Alzheimer's disease
Chami, B.
Steel, A. J.
De La Monte, S. M.
Sutherland, Greg T.
[J]. METABOLIC BRAIN DISEASE, 2016, 31 (03) : 497 - 515
[4] Impaired insulin signaling and the pathogenesis of Alzheimer's disease
Revill, P.
Moral, M. A.
Prous, J. R.
[J]. DRUGS OF TODAY, 2006, 42 (12) : 785 - 790
[5] Deregulation of brain insulin signaling in Alzheimer's disease
Yanxing Chen
Yanqiu Deng
Baorong Zhang
Cheng-Xin Gong
[J]. Neuroscience Bulletin, 2014, 30 (02) : 282 - 294
[6] Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Chen, Yanxing
Zhang, Jianfang
Zhang, Baorong
Gong, Cheng-Xin
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (05) : 485 - 492
[7] Deregulation of brain insulin signaling in Alzheimer’s disease
Yanxing Chen
Yanqiu Deng
Baorong Zhang
Cheng-Xin Gong
[J]. Neuroscience Bulletin, 2014, 30 : 282 - 294
[8] Deregulation of brain insulin signaling in Alzheimer's disease
Chen, Yanxing
Deng, Yanqiu
Zhang, Baorong
Gong, Cheng-Xin
[J]. NEUROSCIENCE BULLETIN, 2014, 30 (02) : 282 - 294
[9] The rise and fall of insulin signaling in Alzheimer’s disease
B. Chami
A. J. Steel
S. M. De La Monte
Greg T. Sutherland
[J]. Metabolic Brain Disease, 2016, 31 : 497 - 515
[10] Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Stanley, Molly
Macauley, Shannon L.
Holtzman, David M.
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (08): : 1375 - 1385

← 1 2 3 4 5 →